HomeAI · summaries
Storia in 18 fonti
Novo Nordisk sagsøger sin største konkurrent
Novo Nordisk mener, at Eli Lilly har benyttet sig af vildledende markedsføring i USA og går nu rettens vej.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs
The lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly superior to Novo’s medicines. Lilly countered that…
- ·
cnbc.com
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.
